| ISIN | LU0996778642 |
|---|---|
| Valorennummer | 58920661 |
| Bloomberg Global ID | |
| Fondsname | Kieger Sustainable Healthcare Fund Class A USD Accumulating |
| Fondsanbieter |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Telefon: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
| Fondsanbieter | Kieger AG |
| Vertreter in der Schweiz |
ACOLIN Fund Services AG Zürich Telefon: +41 44 396 96 96 |
| Distributor(en) | |
| Anlagekategorie | Aktienfonds |
| EFC-Kategorie | |
| Anteilskategorie | Accumulation |
| Domizilland | Luxemburg |
| Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
| Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
| Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager. |
| Besonderheiten |
| Aktueller Preis * | 224.24 USD | 11.12.2025 |
|---|---|---|
| Vorheriger Preis * | 221.71 USD | 10.12.2025 |
| 52 Wochen Hoch * | 229.00 USD | 26.11.2025 |
| 52 Wochen Tief * | 196.79 USD | 07.08.2025 |
| NAV * | 224.24 USD | 11.12.2025 |
| Ausgabepreis * | ||
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 233'684'887 | |
| Anteilsklassevermögen *** | 2'785'920 | |
| Trading Information SIX | ||
| YTD-Performance | +8.07% |
31.12.2024 - 11.12.2025
31.12.2024 11.12.2025 |
|---|---|---|
| YTD-Performance (in CHF) | -5.38% |
31.12.2024 - 11.12.2025
31.12.2024 11.12.2025 |
| 1 Monat | +0.91% |
11.11.2025 - 11.12.2025
11.11.2025 11.12.2025 |
| 3 Monate | +5.38% |
11.09.2025 - 11.12.2025
11.09.2025 11.12.2025 |
| 6 Monate | +5.60% |
11.06.2025 - 11.12.2025
11.06.2025 11.12.2025 |
| 1 Jahr | +3.15% |
11.12.2024 - 11.12.2025
11.12.2024 11.12.2025 |
| 2 Jahre | +13.04% |
11.12.2023 - 11.12.2025
11.12.2023 11.12.2025 |
| 3 Jahre | +13.62% |
12.12.2022 - 11.12.2025
12.12.2022 11.12.2025 |
| 5 Jahre | +32.77% |
11.12.2020 - 11.12.2025
11.12.2020 11.12.2025 |
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 6.36% | |
|---|---|---|
| UnitedHealth Group Inc | 5.85% | |
| Abbott Laboratories | 5.75% | |
| AstraZeneca PLC | 5.68% | |
| Novartis AG Registered Shares | 5.51% | |
| Roche Holding AG | 5.40% | |
| Boston Scientific Corp | 4.02% | |
| Vertex Pharmaceuticals Inc | 4.00% | |
| Novo Nordisk AS Class B | 3.53% | |
| Danaher Corp | 3.44% | |
| Letzte Daten-Aktualisierung | 30.09.2025 | |
| TER *** | 0.99% |
|---|---|
| Datum TER *** | 30.09.2023 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.85% |
| Ongoing Charges *** | 1.26% |
|
SRRI ***
|
|
| Datum SRRI *** | 30.11.2025 |